Similarly, the classification of BRAF mutations, the knowledge about dysregulated signaling pathways and dysregulated circuitries related to these mutations, and the function of BRAF in sarcoma led to the development of new therapeutic options to overcome resistance to conventional chemotherapy. Here, BRAF is linked to sarcoma.